SCHEMBL4427172

SCHEMBL4427172

CCCCC(C(=O)N[C@@H](CC(=O)O)c1cccc(OC(C)C)c1)n1cc(C)cc(Cc2cccc3ccccc23)c1=O

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CASP1 P29466 10/20 0.43
CMA1 P23946 2/20 0.37
MAPT P10636 2/20 0.34
GPR88 Q9GZN0 1/20 0.34
MEN1 O00255 1/20 0.34
LMNA P02545 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
KMT2A Q03164 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
MME P08473 1/20 0.34
ACE P12821 1/20 0.34
CPA1 P15085 1/20 0.34
ACE2 Q9BYF1 1/20 0.34
FPR1 P21462 2/20 0.33
FPR2 P25090 1/20 0.33
TACR3 P29371 1/20 0.33
IDH1 O75874 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4426739 0.93 CASP1 (0.42) CASP1CMA1MAPTFPR1FPR2
SCHEMBL4435242 0.92 CASP1 (0.37) CASP1CMA1GPR88CYP3A4CYP2C9
SCHEMBL4436767 0.91 CASP1 (0.39) CASP1GPR88KMT2AFPR1
SCHEMBL4426779 0.91 FPR1 (0.37) CASP1GPR88KMT2ASMN1; SMN2FPR1
SCHEMBL4434290 0.90 FPR1 (0.39) CASP1GPR88CYP3A4CYP2C9CYP2C19
SCHEMBL4424304 0.90 FPR1 (0.44) CASP1SMN1; SMN2FPR1FPR2
SCHEMBL4427169 0.89 FPR1 (0.37) CASP1GPR88KMT2ASMN1; SMN2FPR1
SCHEMBL4434041 0.88 FPR1 (0.35) CASP1GPR88KMT2ASMN1; SMN2FPR1
SCHEMBL4436791 0.87 KMT2A (0.36) CASP1GPR88KMT2ASMN1; SMN2FPR1
SCHEMBL6759875 0.85 FPR1 (0.43) CASP1MAPTGPR88MEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1213288-B1 Propanoic acid derivatives that inhibit the binding of integrins to their receptors ENCYSIVE PHARMACEUTICALS INC (US) 2009-01-14 EP disclosed
EP-1213288-A1 Propanoic acid derivatives that inhibit the binding of integrins to their receptors TEXAS BIOTECHNOLOGY CORPORATION (US) 2002-06-12 EP disclosed